Edition:
United Kingdom

Cigna Corp (CI.N)

CI.N on New York Stock Exchange

207.09USD
12 Oct 2018
Change (% chg)

$1.09 (+0.53%)
Prev Close
$206.00
Open
$207.76
Day's High
$209.76
Day's Low
$206.03
Volume
490,433
Avg. Vol
530,056
52-wk High
$227.12
52-wk Low
$163.02

Select another date:

Mon, Sep 17 2018

Photo

Cigna deal gets antitrust nod, positive sign for CVS-Aetna

Health insurer Cigna Corp's $52 billion acquisition of pharmacy benefits manager Express Scripts Holding Co has passed U.S. antitrust scrutiny, the companies said on Monday, allowing them to proceed with a combination they say will lead to lower costs by better coordinating pharmacy and medical benefits.

Cigna-Express scripts deal gets anti-trust approval

Sept 17 - Health insurer Cigna Corp's $52 billion acquisition of pharmacy benefits manager Express Scripts Holding Co has passed U.S. antitrust scrutiny, the companies said on Monday, allowing a combination the companies say will lead to lower costs by better coordinating pharmacy and medical benefits.

Deals of the day-Mergers and acquisitions

Aug 24 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Friday:

Cigna, Express Scripts shareholders approve $52 billion deal

Cigna Corp shareholders on Friday voted in favor of the health insurer's proposed $52 billion acquisition of pharmacy benefit manager Express Scripts Holding Co , although the deal still needs clearance from antitrust authorities.

UPDATE 2-Cigna, Express Scripts shareholders approve $52 bln deal

Aug 24 Cigna Corp shareholders on Friday voted in favor of the health insurer's proposed $52 billion acquisition of pharmacy benefit manager Express Scripts Holding Co, although the deal still needs clearance from antitrust authorities.

Cigna shareholders approve $52 bln Express Scripts acquisition

Aug 24 Cigna Corp shareholders on Friday voted in favor of the health insurer's proposed $52 billion acquisition of pharmacy benefit manager Express Scripts Holding Co, but the deal still needs antitrust approval to move forward.

Icahn reverses position on Cigna-Express Scripts deal

Activist investor Carl Icahn said on Monday that he no longer intended to solicit proxies to vote against the $52 billion Cigna-Express Scripts deal, a turn around from his position last week when he urged the health insurer's shareholders to vote against it.

Icahn reverses position on Cigna-Express Scripts deal

Activist investor Carl Icahn said on Monday that he no longer intended to solicit proxies to vote against the $52 billion Cigna-Express Scripts deal, a turn around from his position last week when he urged the health insurer's shareholders to vote against it.

UPDATE 1-Icahn reverses position on Cigna-Express Scripts deal

Aug 13 Activist investor Carl Icahn said on Monday that he no longer intended to solicit proxies to vote against the $52 billion Cigna-Express Scripts deal, a turn around from his position last week when he urged the health insurer's shareholders to vote against it.

Cigna-Express Scripts deal gets backing from another proxy firm

Aug 13 Cigna Corp said Glass Lewis & Co on Monday recommended its shareholders vote in favour for the proposed $52 billion acquisition of pharmacy benefits manager Express Scripts, the second proxy advisory firm to support the deal.

Select another date: